[1] |
付小兵. 中国特色创面修复学科体系建设的内涵[J/CD].中华损伤与修复杂志(电子版),2020,15(1):1-4. DOI: 10.3877/cma.j.issn.1673-9450.2020.01.001.
|
[2] |
付小兵. 不忘初心 牢记使命 努力把中国创面修复科建设好发展好[J].中华烧伤杂志,2020,36(1):1-4. DOI: 10.3760/cma.j.issn.1009-2587.2020.01.001.
|
[3] |
付小兵. 建设规范化和标准化创面修复科在中国的实践[J].中华创伤杂志,2020,36(1):3-5. DOI: 10.3760/cma.j.issn.1001-8050.2020.01.002.
|
[4] |
中国老年医学学会烧创伤分会, 中国医师协会中国创面修复科标准化建设专家委员会, 全国创面修复专科联盟. 创面修复科医师职业标准的全国专家共识[J/CD].中华损伤与修复杂志(电子版),2020,15(4):241-244. DOI: 10.3877/cma.j.issn.1673-9450.2020.04.001.
|
[5] |
付小兵. 如何在中国建立规范化的体表慢性难愈合创面防控培训与教育体系: 我们的初步实践与体会[J].感染、炎症、修复,2019,20(1):23-26. DOI: 10.3969/j.issn.1672-8521.2019.01.002.
|
[6] |
付小兵. 战时治烧伤,平时治创面:有关烧伤学科发展的一点思考[J].中华烧伤杂志,2018,34(7):434-436. DOI: 10.3760/cma.j.issn.1009-2587.2018.07.002.
|
[7] |
XiaoJ, LinZF, QinH, et al. Growth factor regulatory system: a new system for not truly recognized organisms[J]. Sci China Life Sci, 2020,63(3):443-446. DOI: 10.1007/s11427-019-1590-x.
|
[8] |
FuXB. Repair cell first, then regenerate the tissues and organs[J]. Mil Med Res, 2021,8(1):2. DOI: 10.1186/s40779-021-00297-5.
|
[9] |
JiSF, ZhouLX, SunZF, et al. Small molecules facilitate single factor-mediated sweat gland cell reprogramming[J]. Mil Med Res, 2022,9(1):13. DOI: 10.1186/s40779-022-00372-5.
|
[10] |
XiongY, MiBB, LinZ, et al. The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity[J]. Mil Med Res, 2022,9(1):65. DOI: 10.1186/s40779-022-00426-8.
|
[11] |
ZhangW, WangL, SunXH, et al. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice[J]. Mil Med Res, 2021,8(1):16. DOI: 10.1186/s40779-021-00309-4.
|
[12] |
XuHQ, LiuJC, ZhangZY, et al. A review on cell damage, viability, and functionality during 3D bioprinting[J]. Mil Med Res, 2022,9(1):70. DOI: 10.1186/s40779-022-00429-5.
|
[13] |
付小兵, 李校堃. 从第一个用于创烧伤治疗的基因工程国家一类新药研发与转化应用看创烧伤治疗“中国方案”的创立[J]. 中华烧伤与创面修复杂志, 2022, 38(1): 4-8. DOI: 10.3760/cma.j.cn501120-20211125-00397.
|
[14] |
付小兵.治疗创烧伤国家一类新药基因工程生长因子研发与转化应用:主要历程与思索[J].中华创伤杂志,2018,34(12):1057-1061.DOI: 10.3760/cma.j.issn.1001-8050.2018.12.001.
|
[15] |
FuX, ShenZ, ChenY, et al. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns[J]. Lancet, 1998,352(9141):1661-1664. DOI: 10.1016/S0140-6736(98)01260-4.
|
[16] |
付小兵. 创面治疗中的转化医学:部分成果的研发和转化应用与思考[J].中华烧伤杂志,2014,30(1):3-5. DOI: 10.3760/cma.j.issn.1009-2587.2014.01.002.
|
[17] |
付小兵. 进一步强调医学科学研究中基础与临床的密切结合[J].感染、炎症、修复,2008,9(1):3-4. DOI: 10.3969/j.issn.1672-8521.2008.01.001.
|
[18] |
WeiS, WangW, LiL, et al. Recombinant human epidermal growth factor combined with vacuum sealing drainage for wound healing in Bama pigs[J]. Mil Med Res, 2021,8(1):18. DOI: 10.1186/s40779-021-00308-5.
|
[19] |
DonatN, LeclercT, AlmelandSK. Enzymatic debridement shall not modify the global strategy for mass burn events[J]. Mil Med Res, 2022,9(1):66. DOI: 10.1186/s40779-022-00427-7.
|
[20] |
《多学科合作下糖尿病足防治专家共识(2020版)》编写组. 多学科合作下糖尿病足防治专家共识(2020版)精华版(Ⅰ)[J]. 中华烧伤杂志,2020,36 (8): 637-646. DOI: 10.3760/cma.j.cn501120-20200217-00062.
|
[21] |
ManiR. Looking east[J]. Int J Low Extrem Wounds, 2012,11(3):146. DOI: 10.1177/1534734612456921.
|